Wolfram H. Zimmermann

4.1k total citations
37 papers, 2.5k citations indexed

About

Wolfram H. Zimmermann is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wolfram H. Zimmermann has authored 37 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Surgery and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wolfram H. Zimmermann's work include Tissue Engineering and Regenerative Medicine (14 papers), Electrospun Nanofibers in Biomedical Applications (9 papers) and Pluripotent Stem Cells Research (6 papers). Wolfram H. Zimmermann is often cited by papers focused on Tissue Engineering and Regenerative Medicine (14 papers), Electrospun Nanofibers in Biomedical Applications (9 papers) and Pluripotent Stem Cells Research (6 papers). Wolfram H. Zimmermann collaborates with scholars based in Germany, United States and United Kingdom. Wolfram H. Zimmermann's co-authors include Thomas Eschenhagen, Joachim Weil, Christine Fink, Malte Tiburcy, Hansjörg Schäfer, Tetsuro Wakatsuki, Elliot L. Elson, Nanette H. Bishopric, Hasso Scholz and Joseph C. Wu and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Wolfram H. Zimmermann

35 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wolfram H. Zimmermann Germany	20	1.3k	1.2k	879	698	572	37	2.5k
Michael Didié Germany	21	2.0k 1.5×	1.2k 1.0×	1.5k 1.7×	920 1.3×	544 1.0×	40	3.0k
Wuqiang Zhu United States	29	1.1k 0.9×	1.8k 1.5×	564 0.6×	420 0.6×	987 1.7×	78	3.2k
Malte Tiburcy Germany	23	956 0.7×	1.4k 1.2×	482 0.5×	581 0.8×	673 1.2×	54	2.4k
Claudia Bearzi Italy	26	1.6k 1.2×	1.7k 1.4×	674 0.8×	588 0.8×	470 0.8×	58	3.0k
Yibing Qyang United States	28	1.3k 1.0×	2.4k 2.0×	521 0.6×	479 0.7×	388 0.7×	61	3.4k
Maria Papadaki United States	18	934 0.7×	470 0.4×	766 0.9×	616 0.9×	398 0.7×	36	1.7k
Dario Sirabella United States	12	868 0.7×	1.2k 1.0×	285 0.3×	537 0.8×	235 0.4×	19	1.8k
Beatriz Pelacho Spain	31	1.1k 0.9×	1.1k 0.9×	779 0.9×	451 0.6×	345 0.6×	68	2.6k
Veronica Muskheli United States	13	2.5k 2.0×	2.7k 2.2×	1.1k 1.3×	1.1k 1.5×	378 0.7×	14	4.0k
Mark Gagliardi Canada	14	1.2k 0.9×	1.6k 1.4×	429 0.5×	889 1.3×	308 0.5×	17	2.4k

Countries citing papers authored by Wolfram H. Zimmermann

Since Specialization

Citations

This map shows the geographic impact of Wolfram H. Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram H. Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram H. Zimmermann more than expected).

Fields of papers citing papers by Wolfram H. Zimmermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfram H. Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram H. Zimmermann. The network helps show where Wolfram H. Zimmermann may publish in the future.

Co-authorship network of co-authors of Wolfram H. Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfram H. Zimmermann. A scholar is included among the top collaborators of Wolfram H. Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfram H. Zimmermann. Wolfram H. Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Versteeg, Daniëlle, Hesther de Ruiter, Ilaria Perini, et al.. (2023). Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy. Nature Cardiovascular Research. 2(12). 1262–1276. 38 indexed citations

Schoger, Eric, Stephan von Haehling, Laura C. Zelarayán, et al.. (2023). Abstract P1128: CRISPR-mediated Activation Of DLK1 Induces A Regenerative State In Engineered Human Myocardium. Circulation Research. 133(Suppl_1).

Wagner, Gunar, L. Sievers, Malte Tiburcy, et al.. (2022). Impact of Immunosuppressive Drugs on Fibroblasts: An In Vitro Study. Journal of Clinical Medicine. 11(11). 3107–3107. 1 indexed citations

Schmidt, Julia, Steffi Dreha‐Kulaczewski, Maria-Patapia Zafeiriou, et al.. (2022). Somatic mosaicism in STAG2-associated cohesinopathies: Expansion of the genotypic and phenotypic spectrum. Frontiers in Cell and Developmental Biology. 10. 1025332–1025332. 6 indexed citations

Quentin, Thomas, Michael Steinmetz, Maksymilian Prondzynski, et al.. (2018). Mechanistic role of the CREB-regulated transcription coactivator 1 in cardiac hypertrophy. Journal of Molecular and Cellular Cardiology. 127. 31–43. 7 indexed citations

Abilez, Oscar J., Evangeline Tzatzalos, Huaxiao Yang, et al.. (2017). Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling. Stem Cells. 36(2). 265–277. 109 indexed citations

Riegler, Johannes, Malte Tiburcy, Antje Ebert, et al.. (2015). Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model. Circulation Research. 117(8). 720–730. 167 indexed citations

Ritterhoff, Julia, Mirko Völkers, Andreas Seitz, et al.. (2015). S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction. Molecular Therapy. 23(8). 1320–1330. 13 indexed citations

Ritterhoff, Julia, Mirko Völkers, Andreas Seitz, et al.. (2014). Abstract 37: The Positive Inotropic S100a1 Prevents Arrhythmogenic Sarcoplasmic Reticulum Ca2+ Leak And Ventricular Arrhythmias. Circulation Research. 115(suppl_1). 1 indexed citations

10.

Heilmann, Andreas, Michael Didié, Saskia Schlossarek, et al.. (2012). Impact of AT2 Receptor Deficiency on Postnatal Cardiovascular Development. PLoS ONE. 7(10). e47916–e47916. 10 indexed citations

11.

Fredersdorf, Sabine, Wolfram H. Zimmermann, Roland Vetter, et al.. (2012). Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data. Cardiovascular Diabetology. 11(1). 57–57. 43 indexed citations

12.

Huntgeburth, Michael, Klaus Tiemann, Robert Shahverdyan, et al.. (2011). Transforming Growth Factor β1 Oppositely Regulates the Hypertrophic and Contractile Response to β-Adrenergic Stimulation in the Heart. PLoS ONE. 6(11). e26628–e26628. 38 indexed citations

13.

Caglayan, Evren, Marius Vantler, Olli Leppänen, et al.. (2011). Disruption of Platelet-Derived Growth Factor–Dependent Phosphatidylinositol 3-Kinase and Phospholipase Cγ 1 Activity Abolishes Vascular Smooth Muscle Cell Proliferation and Migration and Attenuates Neointima Formation In Vivo. Journal of the American College of Cardiology. 57(25). 2527–2538. 42 indexed citations

14.

Kehat, Izhak, Jennifer Davis, Malte Tiburcy, et al.. (2010). Extracellular Signal-Regulated Kinases 1 and 2 Regulate the Balance Between Eccentric and Concentric Cardiac Growth. Circulation Research. 108(2). 176–183. 197 indexed citations

15.

El‐Armouche, Ali, Alexander Peter Schwoerer, Christiane Neuber, et al.. (2010). Common MicroRNA Signatures in Cardiac Hypertrophic and Atrophic Remodeling Induced by Changes in Hemodynamic Load. PLoS ONE. 5(12). e14263–e14263. 25 indexed citations

16.

Deuse, T., Christoph Peter, Paul W.M. Fedak, et al.. (2009). Hepatocyte Growth Factor or Vascular Endothelial Growth Factor Gene Transfer Maximizes Mesenchymal Stem Cell–Based Myocardial Salvage After Acute Myocardial Infarction. Circulation. 120(11_suppl_1). S247–54. 177 indexed citations

17.

El‐Armouche, Ali, Katrin Wittköpper, Florian Weinberger, et al.. (2008). Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovascular Research. 80(3). 396–406. 80 indexed citations

18.

Eschenhagen, Thomas & Wolfram H. Zimmermann. (2005). Engineering Myocardial Tissue. Circulation Research. 97(12). 1220–1231. 188 indexed citations

19.

Vantler, Marius, Evren Caglayan, Wolfram H. Zimmermann, Anselm T. Bäumer, & Stephan Rosenkranz. (2005). Systematic Evaluation of Anti-apoptotic Growth Factor Signaling in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 280(14). 14168–14176. 47 indexed citations

20.

Remppis, Andrew, Sven T. Pleger, Patrick Most, et al.. (2004). S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts. The Journal of Gene Medicine. 6(4). 387–394. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact